secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0000950170-24-112038
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences: Final Medicare LCDs confirm coverage for OMNI and SION procedures but impose usage limitations
--------------------------------------------------------------------------------

- Four MACs (Palmetto GBA, CGS, NGS, WPS) published final LCDs effective Nov 17, 2024, confirming coverage for single MIGS with phaco.
- Coverage continues for canaloplasty/trabeculotomy (OMNI) and goniotomy (SION) procedures.
- Limitations: non-coverage for first-line mild-to-moderate glaucoma, combined MIGS with aqueous shunt, and phaco with multiple MIGS.
- Sight Sciences plans to engage with MACs, CMS, and clinical societies on coverage issues.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/0000950170-24-112038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/sght-20241003.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-112038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer